We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Binimetinib Nitroso Impurity 2
Binimetinib Nitroso Impurity 2
CAT No SRC-N0144163
CAS No NA
Mol.F. C19H16BrF2N5O4
Mol.Wt. 496.3 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso N-Desmethyl Binimetinib
N-Nitroso N-Desmethyl Binimetinib
CAT No SRC-N0144164
CAS No NA
Mol.F. C16H12BrF2N5O4
Mol.Wt. 456.2 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Binimetinib Des Bromo Vinyloxy Impurity
N-Nitroso Binimetinib Des Bromo Vinyloxy Impurity
CAT No SRC-N0144165
CAS No NA
Mol.F. C19H17F2N5O4
Mol.Wt. 417.37 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Binimetinib Ethyl Ether Impurity
N-Nitroso Binimetinib Ethyl Ether Impurity
CAT No SRC-N0144166
CAS No NA
Mol.F. C19H18BrF2N5O4
Mol.Wt. 498.28 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Methylmethoxymethylamine
N-Nitroso Methylmethoxymethylamine
CAT No SRC-N0144167
CAS No 39885-14-8
Mol.F. C3H8N2O2
Mol.Wt. 104.1 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso-N-Phenyl-3-Aminopropanoic Acid
N-Nitroso-N-Phenyl-3-Aminopropanoic Acid
CAT No SRC-N0144168
CAS No 98953-10-7
Mol.F. C9H10N2O3
Mol.Wt. 194.2 g/mole
INV STATUS CUSTOM SYNTHESIS
Nitrosamines Impurity 97
Nitrosamines Impurity 97
CAT No SRC-N0144169
CAS No NA
Mol.F. C8H17N3O
Mol.Wt. 171.2 g/mole
INV STATUS CUSTOM SYNTHESIS
Nitrosamines Impurity 98
Nitrosamines Impurity 98
CAT No SRC-N0144170
CAS No NA
Mol.F. C7H9N3O2
Mol.Wt. 167.2 g/mole
INV STATUS CUSTOM SYNTHESIS
Nitrous Hydrazide
Nitrous Hydrazide
CAT No SRC-N0144171
CAS No 42363-85-9
Mol.F. H3N3O
Mol.Wt. 61.0 g/mole
INV STATUS CUSTOM SYNTHESIS
N-methyl-N-nitroso Acetamide
N-methyl-N-nitroso Acetamide
CAT No SRC-N0144172
CAS No 7417-67-6
Mol.F. C3H6N2O2
Mol.Wt. 102.1 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitoso-4-benzoyl-3,5-dimethyl piperazine
N-Nitoso-4-benzoyl-3,5-dimethyl piperazine
CAT No SRC-N0144173
CAS No 61034-40-0
Mol.F. C13H17N3O2
Mol.Wt. 247.3 g/mole
INV STATUS CUSTOM SYNTHESIS
N-nitrosamine
N-nitrosamine
CAT No SRC-N0144174
CAS No 35576-91-1
Mol.F. H2N2O
Mol.Wt. 46.0 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Bicisate
N-Nitroso Bicisate
CAT No SRC-N0144175
CAS No NA
Mol.F. C12H23N3O5S2
Mol.Wt. 353.5 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Brilliant Blue G
N-Nitroso Brilliant Blue G
CAT No SRC-N0144176
CAS No NA
Mol.F. C47H47N4O8S2
Mol.Wt. 860.0 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso methyl (2-oxopropyl) amine
N-Nitroso methyl (2-oxopropyl) amine
CAT No SRC-N0144177
CAS No 55984-51-5
Mol.F. C4H8N2O2
Mol.Wt. 116.1 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Methyl Urea
N-Nitroso Methyl Urea
CAT No SRC-N0144178
CAS No 684-93-5
Mol.F. C2H5N3O2
Mol.Wt. 103.1 g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.